244,993 studies176,840 in plain language

Find a clinical trial.Understand what it says.

breast cancer, recruiting diabetes near Boston phase 3 Alzheimer's

As written

A Phase 2, randomized, double-blind, placebo-controlled, multicentre study to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of the investigational agent administered subcutaneously every four weeks in adult participants meeting protocol-defined inclusion and exclusion criteria, with the primary endpoint assessed at week 24 by change from baseline in the composite response index, and secondary endpoints including incidence of treatment-emergent adverse events through the end-of-study visit.

What it means

This study is testing whether a new treatment is safe, and whether it looks like it helps.
It is an injection every four weeks, and it runs for about six months.
Half the people in it receive the treatment and half receive a placebo. Neither they nor their doctor knows which.

The same clarity, for your own appointments.

Clareo writes up your visits, keeps the next steps in one place, and answers questions from what was actually said.

Start free

Everywhere they run

Pick a city for what is recruiting there now.

Clareo does not run these studies and cannot enrol you in one. We restate public information to make it easier to read, and to help you ask better questions of your own care team.

Data from ClinicalTrials.govTerms